|
ace2 |
13 |
|
covid-19 |
13 |
|
rnai |
13 |
|
sace2 |
13 |
|
sars-cov-2 |
13 |
|
animals |
12 |
|
lupus nephritis |
12 |
|
fibrosis |
10 |
|
inflammation |
10 |
|
peritoneal dialysis |
10 |
|
ascitic fluid |
8 |
|
carcinoma/metabolism |
8 |
|
carcinoma/secondary |
8 |
|
cell adhesion |
8 |
|
hepatitis b |
8 |
|
ovarian cancer |
7 |
|
cytokines |
6 |
|
decorin |
6 |
|
fibronectin |
6 |
|
kidney transplantation |
6 |
|
mycophenolic acid |
6 |
|
nephritis |
6 |
|
proximal renal tubular epithelial cells |
6 |
|
anti-dsdna antibodies |
5 |
|
antiviral agents - adverse effects - therapeutic use |
5 |
|
dose-response relationship, drug |
5 |
|
female |
5 |
|
humans |
5 |
|
hyaluronan |
5 |
|
male |
5 |
|
peritoneal mesothelial cells |
5 |
|
peritonitis |
5 |
|
pharmacokinetics |
5 |
|
proximal tubular epithelial cells |
5 |
|
3d culture |
4 |
|
adenine - analogs and derivatives - therapeutic use |
4 |
|
adhesion |
4 |
|
adult |
4 |
|
amino acid |
4 |
|
biocompatibility |
4 |
|
bioengineering |
4 |
|
cell proliferation |
4 |
|
co-culture |
4 |
|
creatinine - blood |
4 |
|
dyslipidaemia |
4 |
|
endothelial cells |
4 |
|
entecavir |
4 |
|
gene expression |
4 |
|
hepatitis b, chronic - complications - diagnosis - drug therapy - mortality |
4 |
|
icodextrin |
4 |
|
immunohistochemistry |
4 |
|
immunosuppressive agents - pharmacology |
4 |
|
intercellular adhesion molecule-1 |
4 |
|
ischemia-reperfusion injury |
4 |
|
issue 120 |
4 |
|
kidney |
4 |
|
kidney - metabolism - pathology |
4 |
|
kidney diseases - complications - surgery |
4 |
|
kidney diseases - drug therapy - therapy |
4 |
|
kidney transplantation - adverse effects - mortality |
4 |
|
kidney tubules - cytology |
4 |
|
lamivudine |
4 |
|
lipoproteins |
4 |
|
ln |
4 |
|
medical sciences |
4 |
|
mesangial cells |
4 |
|
metastasis |
4 |
|
mice |
4 |
|
mice, inbred balb c |
4 |
|
microfluidics |
4 |
|
middle aged |
4 |
|
multicellular spheroids |
4 |
|
p-cadherin |
4 |
|
p70 s6 kinase |
4 |
|
p70s6k |
4 |
|
peritoneal adhesion |
4 |
|
peritoneal inflammation |
4 |
|
rapamycin |
4 |
|
renal |
4 |
|
reperfusion injury - pathology |
4 |
|
resistance |
4 |
|
reverse transcriptase polymerase chain reaction |
4 |
|
shear stress |
4 |
|
sirolimus - pharmacology |
4 |
|
syndecan-1 |
4 |
|
thrombomodulin |
4 |
|
transplantation |
4 |
|
tubular cells |
4 |
|
vascular cell adhesion molecule-1 |
4 |
|
β1 integrin |
4 |
|
acute kidney injury |
3 |
|
adenine - analogs & derivatives - pharmacology - therapeutic use |
3 |
|
administration, oral |
3 |
|
adolescent |
3 |
|
aged |
3 |
|
aki |
3 |
|
alanine transaminase - blood |
3 |
|
albuminuria - chemically induced - drug therapy - immunology |
3 |
|
albuminuria - drug therapy |
3 |
|
antibiotics, antineoplastic - toxicity |
3 |
|
antibodies, antinuclear - immunology |
3 |
|
anticholesteremic agents - administration & dosage |
3 |
|
antiphospholipid antibodies |
3 |
|
antiviral agents - therapeutic use |
3 |
|
autoimmunity |
3 |
|
b cell depletion |
3 |
|
b cell signatures |
3 |
|
b cells |
3 |
|
blotting, western |
3 |
|
body weight |
3 |
|
c-reactive protein - analysis |
3 |
|
cancer nanomedicine |
3 |
|
cancer stem cells |
3 |
|
cell proliferation - drug effects |
3 |
|
cells, cultured |
3 |
|
chemokine ccl2 - biosynthesis - genetics |
3 |
|
chemokine ccl5 - genetics |
3 |
|
chemokine ccl5 - metabolism |
3 |
|
cohort studies |
3 |
|
collagen type i - genetics |
3 |
|
creatinine - metabolism |
3 |
|
dendrimer nanovector |
3 |
|
dialysis |
3 |
|
disease models, animal |
3 |
|
disease relapse |
3 |
|
dna, viral - analysis |
3 |
|
doxorubicin - toxicity |
3 |
|
drug resistance, viral |
3 |
|
emerging therapies |
3 |
|
emodin |
3 |
|
emodin - pharmacology |
3 |
|
emt |
3 |
|
enzyme inhibitors - pharmacology |
3 |
|
enzyme-linked immunosorbent assay |
3 |
|
epithelium - metabolism - pathology |
3 |
|
epr effect |
3 |
|
fibronectins - biosynthesis - genetics |
3 |
|
focal segmental glomerulosclerosis |
3 |
|
gene expression - drug effects - immunology |
3 |
|
glomerulosclerosis |
3 |
|
glomerulosclerosis, focal segmental - chemically induced - drug therapy - immunology |
3 |
|
glucose |
3 |
|
glucose - pharmacology |
3 |
|
guanine - analogs & derivatives - pharmacology - therapeutic use |
3 |
|
hepatitis b - complications - drug therapy |
3 |
|
hepatitis c |
3 |
|
hepatitis c, chronic - complications - drug therapy |
3 |
|
heptanoic acids - administration & dosage |
3 |
|
immunoglobulin g |
3 |
|
immunoglobulins |
3 |
|
immunosuppressive agents - administration & dosage |
3 |
|
immunosuppressive agents - pharmacology - therapeutic use |
3 |
|
interferon-alpha - adverse effects - therapeutic use |
3 |
|
interstitial fibrosis |
3 |
|
kidney - drug effects |
3 |
|
kidney - immunology - pathology |
3 |
|
kidney - metabolism |
3 |
|
kidney glomerulus - immunology - metabolism - pathology |
3 |
|
kidney inflammation |
3 |
|
ku70 |
3 |
|
lamivudine - therapeutic use |
3 |
|
lamivudine resistance |
3 |
|
long term |
3 |
|
lupus |
3 |
|
lupus nephritis - drug therapy - pathology |
3 |
|
lupus nephritis - immunology - pathology - prevention & control |
3 |
|
lupus nephritis pathogenesis |
3 |
|
mannitol - pharmacology |
3 |
|
mesothelial cells |
3 |
|
mice, inbred nzb |
3 |
|
mir-200c |
3 |
|
mitogen-activated protein kinase (mapk) |
3 |
|
mycophenolate mofetil |
3 |
|
non-viral delivery |
3 |
|
nzb/w f1 mice |
3 |
|
outcomes |
3 |
|
pathogenesis |
3 |
|
pegylated interferon |
3 |
|
peritoneum |
3 |
|
peritoneum - metabolism - pathology |
3 |
|
phosphonic acids - pharmacology - therapeutic use |
3 |
|
pilot projects |
3 |
|
polyethylene glycols - adverse effects - therapeutic use |
3 |
|
proteinuria |
3 |
|
pyrroles - administration & dosage |
3 |
|
recombinant proteins |
3 |
|
renal allograft recipient |
3 |
|
renal dialysis |
3 |
|
renal failure |
3 |
|
rna, messenger - genetics |
3 |
|
rna, viral - analysis |
3 |
|
rnai therapy |
3 |
|
severity of illness index |
3 |
|
sirna delivery |
3 |
|
sirolimus - administration & dosage |
3 |
|
sirolimus - pharmacology - therapeutic use |
3 |
|
sle |
3 |
|
splenomegaly |
3 |
|
subsets |
3 |
|
survival rate |
3 |
|
t-lymphocytes - immunology |
3 |
|
targeted therapy |
3 |
|
tgf-β1 |
3 |
|
tgfβ1 |
3 |
|
time factors |
3 |
|
transforming growth factor beta - biosynthesis - genetics |
3 |
|
transforming growth factor beta1 |
3 |
|
treatment |
3 |
|
treatment outcome |
3 |
|
viral load - drug effects |
3 |
|
25-hydroxyvitamin d |
2 |
|
abstracting, bibliographies, statistics medical sciences |
2 |
|
actin cytoskeleton - physiology |
2 |
|
actinin - metabolism |
2 |
|
akt |
2 |
|
allergology and immunology medical sciences |
2 |
|
amino acids |
2 |
|
annexin a2 - genetics - metabolism |
2 |
|
anti-dna antibodies |
2 |
|
antibodies, anti-idiotypic - metabolism |
2 |
|
antibodies, antinuclear - blood - immunology |
2 |
|
antibodies, antinuclear - pharmacology |
2 |
|
antibodies, antinuclear - physiology |
2 |
|
antigen-antibody complex |
2 |
|
autoimmune diseases |
2 |
|
b cell |
2 |
|
bicarbonate |
2 |
|
bicarbonates |
2 |
|
biglycan |
2 |
|
biochemistry abstracting and indexing services |
2 |
|
biocompatible materials |
2 |
|
biological markers - metabolism |
2 |
|
biopsy |
2 |
|
buffers |
2 |
|
calcifediol |
2 |
|
carcinogens - pharmacology |
2 |
|
catheters, indwelling - adverse effects |
2 |
|
cd14 |
2 |
|
cd4+t cells |
2 |
|
cd4-positive t-lymphocytes - immunology - metabolism |
2 |
|
cd40l |
2 |
|
cell culture techniques |
2 |
|
cell culture techniques - methods |
2 |
|
cell differentiation |
2 |
|
cell differentiation - drug effects |
2 |
|
cell division - drug effects |
2 |
|
cell line |
2 |
|
chinese |
2 |
|
chronic microbial infections |
2 |
|
co-stimulatory molecules |
2 |
|
cognitive impairment |
2 |
|
collagen type i - metabolism |
2 |
|
continuous ambulatory peritoneal dialysis |
2 |
|
cross-sectional studies |
2 |
|
cyclic amp response element-binding protein - metabolism |
2 |
|
cyclophosphamide |
2 |
|
cytokeratin |
2 |
|
dialysis solutions |
2 |
|
dialysis solutions - adverse effects |
2 |
|
dialysis solutions - chemistry - pharmacology |
2 |
|
dialysis solutions - pharmacology |
2 |
|
dna - immunology |
2 |
|
dna methylation |
2 |
|
dna, viral - blood |
2 |
|
e4bp4 |
2 |
|
ebf1 |
2 |
|
epigenetics |
2 |
|
epithelial cells - drug effects - metabolism |
2 |
|
epithelial cells - metabolism |
2 |
|
epithelial cells - metabolism - pathology |
2 |
|
epithelial cells - metabolism - secretion |
2 |
|
epithelial cells - physiology |
2 |
|
epithelial-to- mesenchymal transdifferentiation |
2 |
|
epithelial-to-mesenchymal transdifferentiation |
2 |
|
epithelium |
2 |
|
experimental medicine, laboratory technique |
2 |
|
extracellular matrix |
2 |
|
extracellular matrix proteins - metabolism |
2 |
|
fibronectins - biosynthesis |
2 |
|
fibronectins - metabolism |
2 |
|
flow cytometry |
2 |
|
focal adhesions - metabolism |
2 |
|
foxp3 |
2 |
|
foxp3 tsdr |
2 |
|
gene expression regulation |
2 |
|
glomerular basement membrane - immunology |
2 |
|
glomerular mesangium - cytology - metabolism |
2 |
|
glomerular mesangium - immunology |
2 |
|
glomerular mesangium - metabolism |
2 |
|
glomerulonephritis, iga - metabolism - pathology |
2 |
|
glucans |
2 |
|
glucose - metabolism |
2 |
|
glucuronosyltransferase - genetics |
2 |
|
glycosaminoglycans |
2 |
|
glycosaminoglycans - biosynthesis - physiology |
2 |
|
glycosaminoglycans - metabolism |
2 |
|
gut microbiota |
2 |
|
has-mir-1246 |
2 |
|
heparan sulfate proteoglycans - biosynthesis |
2 |
|
heparin |
2 |
|
hepatitis b - drug therapy - epidemiology |
2 |
|
hepatitis b surface antigens - blood |
2 |
|
hepatitis b virus |
2 |
|
histone modification |
2 |
|
histone modifications |
2 |
|
hmgb1 protein - genetics - metabolism |
2 |
|
hrm-pcr |
2 |
|
human mesangial cells |
2 |
|
human peritoneal mesothelial cells |
2 |
|
hyaluronan synthase |
2 |
|
hyaluronic acid - biosynthesis |
2 |
|
hyaluronic acid - biosynthesis - blood - metabolism |
2 |
|
hyaluronic acid - metabolism - secretion |
2 |
|
icaritin |
2 |
|
il-17 |
2 |
|
il-1b |
2 |
|
il17a |
2 |
|
immunoglobulin g - immunology |
2 |
|
inflammation - etiology |
2 |
|
inflammation - metabolism |
2 |
|
inflammation - physiopathology |
2 |
|
integrins |
2 |
|
interleukin-1 - physiology |
2 |
|
kidney - drug effects - metabolism - pathology |
2 |
|
kidney - immunology - physiopathology |
2 |
|
kidney diseases - metabolism - physiopathology |
2 |
|
kidney failure, chronic - pathology - therapy |
2 |
|
kidney failure, chronic - therapy |
2 |
|
kidney tubules, proximal - cytology - metabolism |
2 |
|
lipopolysaccharide |
2 |
|
lipopolysaccharide binding protein |
2 |
|
longitudinal studies |
2 |
|
lupus erythematosus, systemic - blood - immunology |
2 |
|
lupus erythematosus, systemic - genetics - immunology - metabolism |
2 |
|
lupus nephritis - complications |
2 |
|
lupus nephritis - drug therapy - metabolism - pathology |
2 |
|
lupus nephritis - etiology - metabolism |
2 |
|
lupus nephritis - immunology - physiopathology |
2 |
|
lupus nephritis - metabolism - pathology |
2 |
|
medical sciences medical sciences |
2 |
|
membrane glycoproteins - genetics - metabolism |
2 |
|
mesangial cells - metabolism - pathology |
2 |
|
metalloproteinases |
2 |
|
methylprednisolone |
2 |
|
microrna |
2 |
|
micrornas |
2 |
|
microvilli |
2 |
|
mycophenolic acid - analogs and derivatives - pharmacology - therapeutic use |
2 |
|
omentum |
2 |
|
p53 |
2 |
|
peritoneal dialysis - adverse effects |
2 |
|
peritoneal dialysis fluids |
2 |
|
peritoneal diseases - metabolism |
2 |
|
peritoneal fibroblasts |
2 |
|
peritoneal fibrosis |
2 |
|
peritoneal fibrosis - etiology - prevention & control |
2 |
|
peritoneum - cytology |
2 |
|
peritoneum - cytology - drug effects - metabolism |
2 |
|
peritoneum - drug effects |
2 |
|
peritoneum - metabolism |
2 |
|
peritoneum - metabolism - physiopathology |
2 |
|
peritoneum - pathology |
2 |
|
peritoneum - pathology - physiology |
2 |
|
peritoneum - physiopathology |
2 |
|
peritonitis - blood - etiology - physiopathology |
2 |
|
peritonitis - etiology - metabolism - pathology |
2 |
|
perlecan |
2 |
|
ph neutral |
2 |
|
phosphorylation - drug effects |
2 |
|
pkc |
2 |
|
proliferation |
2 |
|
protein binding |
2 |
|
protein kinase c - metabolism |
2 |
|
protein kinase c-alpha |
2 |
|
protein-tyrosine kinases - metabolism |
2 |
|
proteoglycans |
2 |
|
proteoglycans - biosynthesis |
2 |
|
proteoglycans - biosynthesis - physiology |
2 |
|
proteoglycans - genetics - metabolism |
2 |
|
proteoglycans - metabolism |
2 |
|
psoriasis |
2 |
|
pyruvaldehyde - metabolism - toxicity |
2 |
|
randomized controlled trial |
2 |
|
recovery of function |
2 |
|
regulatory t cells |
2 |
|
renal fibrosis |
2 |
|
renal impairment |
2 |
|
renal insufficiency - immunology - physiopathology |
2 |
|
renal transplantation |
2 |
|
residual renal function |
2 |
|
retrospective studies |
2 |
|
rheumatology |
2 |
|
rheumatology biology |
2 |
|
rna, messenger - analysis |
2 |
|
rna, messenger - metabolism |
2 |
|
senescence |
2 |
|
signal transduction |
2 |
|
statistics, nonparametric |
2 |
|
sulfur radioisotopes - diagnostic use |
2 |
|
synapse |
2 |
|
syndecan |
2 |
|
syndecan-4 |
2 |
|
systemic lupus erythematosus |
2 |
|
t cells |
2 |
|
tau phosphorylation |
2 |
|
tetradecanoylphorbol acetate - pharmacology |
2 |
|
thrombospondin 1 - drug effects - genetics - physiology |
2 |
|
tlr2 |
2 |
|
transcriptome |
2 |
|
transforming growth factor beta - metabolism |
2 |
|
transforming growth factor beta - metabolism - secretion |
2 |
|
transforming growth factor beta1 - metabolism |
2 |
|
transforming growth factor-β1 |
2 |
|
trombospondin-1 |
2 |
|
up-regulation |
2 |
|
up-regulation - drug effects |
2 |
|
urology and nephrology |
2 |
|
urology and nephrology medical sciences |
2 |
|
vasculopathy |
2 |
|
vimentin |
2 |
|
virus activation |
2 |
|
vitamin d deficiency |
2 |
|
aged, 80 and over |
1 |
|
ascitic fluid - chemistry |
1 |
|
ascitic fluid - metabolism |
1 |
|
base sequence |
1 |
|
blood physiological phenomena |
1 |
|
burkitt lymphoma - virology |
1 |
|
cell behavior |
1 |
|
cell division - physiology |
1 |
|
cell movement - drug effects |
1 |
|
chondroitin sulfates - biosynthesis |
1 |
|
chondroitin sulfates - chemistry - isolation & purification - metabolism |
1 |
|
chromatography, gel |
1 |
|
cytokine |
1 |
|
cytokines - pharmacology |
1 |
|
cytoskeleton - physiology |
1 |
|
dermatan sulfate - biosynthesis |
1 |
|
dermatan sulfate - isolation & purification - metabolism |
1 |
|
dialysate |
1 |
|
dialysis solutions - analysis |
1 |
|
dialysis solutions - metabolism |
1 |
|
end-stage renal failure |
1 |
|
endocytosis |
1 |
|
epithelial cells |
1 |
|
epithelium - drug effects |
1 |
|
epithelium - drug effects - pathology - physiopathology |
1 |
|
epithelium - enzymology |
1 |
|
epithelium - injuries - metabolism - pathology - physiopathology |
1 |
|
epithelium - metabolism |
1 |
|
extracellular matrix - physiology |
1 |
|
extracellular matrix proteins |
1 |
|
glucuronosyltransferase - metabolism |
1 |
|
glycosyltransferases |
1 |
|
has gene expression |
1 |
|
hemoglobins |
1 |
|
herpesvirus 4, human - genetics |
1 |
|
hyaluronic acid - biosynthesis - chemistry |
1 |
|
hyaluronic acid - biosynthesis - metabolism |
1 |
|
hyaluronic acid - isolation & purification - metabolism |
1 |
|
infection |
1 |
|
interleukin-1 - pharmacology |
1 |
|
lymphoma, b-cell - etiology - virology |
1 |
|
matrix metalloproteinase |
1 |
|
matrix metalloproteinase 2 - metabolism |
1 |
|
matrix metalloproteinase 3 - metabolism |
1 |
|
matrix metalloproteinases - drug effects - metabolism |
1 |
|
membrane proteins |
1 |
|
mesothelial cell migration |
1 |
|
molecular sequence data |
1 |
|
omentum - cytology - metabolism |
1 |
|
peritoneal cavity - cytology |
1 |
|
peritoneal dialysis, continuous ambulatory |
1 |
|
peritoneal injury |
1 |
|
peritoneum - cytology - enzymology |
1 |
|
peritoneum - drug effects - injuries - pathology - physiopathology |
1 |
|
peritoneum - injuries - metabolism - pathology - physiopathology |
1 |
|
peritonitis - metabolism |
1 |
|
peritonitis - physiopathology |
1 |
|
polymerase chain reaction - methods |
1 |
|
promoter regions (genetics) |
1 |
|
proteoglycans - analysis |
1 |
|
proteoglycans - chemistry - isolation & purification - metabolism |
1 |
|
sensitivity and specificity |
1 |
|
tissue distribution |
1 |
|
tissue inhibitors of metalloproteinases |
1 |
|
tissue repair |
1 |
|
transferases |
1 |
|
transforming growth factor beta - pharmacology |
1 |
|
wound healing - drug effects |
1 |
|
wound healing - drug effects - physiology |
1 |
|
wound repair |
1 |
|
wounds and injuries - metabolism - pathology - physiopathology |
1 |
|
xenopus proteins |
1 |
